Evaluation of Tolerance, Efficacy and Safety of an Hydrolyzed Formula in Infants With IgE/Non-IgE Mediated CMA.

Clinical trial NCT06481280 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06481280
Sponsor: United Pharmaceuticals
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Cow's Milk Allergy

Start date: 2024-08-14
Primary completion: 2026-01-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.